NTRA - ナテラ (Natera Inc.)

NTRAのニュース

   Natera, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:NTRA)  2022/08/05 21:44:25 Seeking Alpha
The following slide deck was published by Natera, Inc.
   Natera: Q2 Earnings Snapshot  2022/08/04 22:37:20 mySA
AUSTIN, Texas (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $145.2 million in its second quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of $1.50. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.47 per share. The genetic testing company posted revenue of $198.2 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $194.1 million. Natera expects full-year revenue in the range of $805 million to $825 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRA
   Natera GAAP EPS of -$1.50 in-line, revenue of $198.2M beats by $4.53M  2022/08/04 20:21:54 Seeking Alpha
Natera press release (NTRA): Q2 GAAP EPS of -$1.50 in-line.Revenue of $198.2M (+39.5% Y/Y) beats by $4.53M.Natera anticipates 2022 total revenue of $805 million to $825 million;…
   Natera Reports Second Quarter 2022 Financial Results  2022/08/04 20:05:00 PR Newswire
AUSTIN, Texas, Aug. 4, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the second quarter ended June 30, 2022 and provided an update on recent business progress and financial outlook. Recent Accomplishments &…
   Natera Q2 2022 Earnings Preview (NASDAQ:NTRA)  2022/08/03 21:35:51 Seeking Alpha
Natera (NTRA) is scheduled to announce Q2 earnings results on Thursday, August 4th, after market close.The consensus EPS Estimate is -$1.50 and the consensus Revenue Estimate is…
   Natera Inc. (NASDAQ:NTRA) Shares Plunged -8.78% In A Week – But Will They Keep Going Up?  2022/07/01 12:00:00 Marketing Sentinel
In last trading session, Natera Inc. (NASDAQ:NTRA) saw 1.04 million shares changing hands with its beta currently measuring 1.15. Company’s recent per share price level of $35.44 trading at -$1.43 or -3.88% at ring of the bell on the day assigns it a market valuation of $3.20B. That closing price of NTRA’s stock is at … Natera Inc. (NASDAQ:NTRA) Shares Plunged -8.78% In A Week – But Will They Keep Going Up? Read More »
   The Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030  2022/06/29 09:53:00 GlobeNewswire
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type; By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com''s offering. The global carrier screening market size is expected to reach USD 3.64 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth. The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques. Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish to discover if their genetic or inherited disorders might be transmitted to their offerings.
   Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Natera, Inc. (NTRA) Investors of Class Action and Encourages Investors to Actively Participate  2022/06/27 15:00:00 Business Wire
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Natera, Inc. (
   FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm  2022/06/27 12:30:00 PR Newswire
LOS ANGELES, June 27, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Natera, Inc. ("Natera" or "the Company") (NASDAQ: NTRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
   NTRA FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRA  2022/06/26 17:45:00 Kwhen Finance
   NTRA SHAREHOLDER ALERT: Jakubowitz Law Reminds Natera Shareholders of a Lead Plaintiff Deadline of June 27, 2022  2022/05/06 09:45:00 PR Newswire
NEW YORK, May 6, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Natera, Inc. (NASDAQ: NTRA). To receive updates on the lawsuit, fill out the form:…
   Natera: Q1 Earnings Snapshot  2022/05/05 21:32:04 mySA
AUSTIN, Texas (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $138.6 million in its first quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of $1.45. The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.50 per share. The genetic testing company posted revenue of $194.1 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $178.5 million. Natera expects full-year revenue in the range of $790 million to $810 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRA
   Natera GAAP EPS of -$1.45 beats by $0.04, revenue of $194.13M beats by $17.52M  2022/05/05 20:18:15 Seeking Alpha
Natera press release (NTRA): Q1 GAAP EPS of -$1.45 beats by $0.04.Revenue of $194.13M (+27.5% Y/Y) beats by $17.52M.
   Natera Reports First Quarter 2022 Financial Results  2022/05/05 20:05:00 PR Newswire
AUSTIN, Texas, May 5, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2022 and provided an update on recent business progress and financial outlook. Recent Accomplishments &…
   NTRA INVESTORS: June 27, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser  2022/05/05 19:25:00 Business Wire
SAN FRANCISCO--(BUSINESS WIRE)---- $NTRA #InvestorAlert--NTRA INVESTORS: June 27, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

calendar